| 000 | 01790 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517052025.0 | ||
| 264 | 0 | _c20160722 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2015.242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeter, B | |
| 245 | 0 | 0 |
_aTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. _h[electronic resource] |
| 260 |
_bLeukemia _cFeb 2016 |
||
| 300 |
_a464-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBasophils _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistamine Release _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 |
_aMastocytosis _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-kit _xmetabolism |
| 650 | 0 | 4 |
_aStaurosporine _xanalogs & derivatives |
| 700 | 1 | _aWinter, G E | |
| 700 | 1 | _aBlatt, K | |
| 700 | 1 | _aBennett, K L | |
| 700 | 1 | _aStefanzl, G | |
| 700 | 1 | _aRix, U | |
| 700 | 1 | _aEisenwort, G | |
| 700 | 1 | _aHadzijusufovic, E | |
| 700 | 1 | _aGridling, M | |
| 700 | 1 | _aDutreix, C | |
| 700 | 1 | _aHoermann, G | |
| 700 | 1 | _aSchwaab, J | |
| 700 | 1 | _aRadia, D | |
| 700 | 1 | _aRoesel, J | |
| 700 | 1 | _aManley, P W | |
| 700 | 1 | _aReiter, A | |
| 700 | 1 | _aSuperti-Furga, G | |
| 700 | 1 | _aValent, P | |
| 773 | 0 |
_tLeukemia _gvol. 30 _gno. 2 _gp. 464-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2015.242 _zAvailable from publisher's website |
| 999 |
_c25241393 _d25241393 |
||